Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration‐resistant prostate cancer-Reference-Cited by-同舟云学术

Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration‐resistant prostate cancer

Published:2022-06-23 Issue:13 Volume:82 Page:1284-1292
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Yang Tao¹,Liu Ying¹,Chen Shuzhen²,Tian Jiale³,Zhu Xuyou⁴,Zhang Long⁴,Wang Wei⁵,Qin Yingyi⁶,Richter Jens⁷,Anand Aseem⁷,Xu Chengdang¹,Chi Yongnan¹,Wang Chenyang¹,Bian Cuidong¹,Wu Denglong¹,Li Zhenfei¹⁸,Huang Shengsong¹^ORCID

Affiliation:

1. Department of Urology, Tongji Hospital, School of Medicine Tongji University Shanghai China

2. Department of Nuclear Medicine, Tongji Hospital, School of Medicine Tongji University Shanghai China

3. Department of Laboratory Medicine, Tongji Hospital, School of Medicine Tongji University Shanghai China

4. Department of Pathology, Tongji Hospital, School of Medicine Tongji University Shanghai China

5. Department of Radiology, Tongji Hospital, School of Medicine Tongji University Shanghai China

6. Department of Health Statistics Naval Medical University Shanghai China

7. Department of Digital Imaging Biomarkers EXINI Diagnostics AB Lund Sweden

8. State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology Chinese Academy of Sciences Shanghai China

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24402

Reference33 articles.

1. Cancer Statistics, 2021

2. Androgens in prostate cancer: A tale that never ends

3. Androgen Deprivation Therapy for Prostate Cancer

4. Abiraterone and Increased Survival in Metastatic Prostate Cancer

5. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perineural Invasion as a Risk Factor For Soft Tissue Progression in Patients With Metastatic Castration-Resistant Prostate Cancer After Abiraterone Resistance;Clinical Genitourinary Cancer;2024-05

2. PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling;Cell Death & Disease;2024-02-10

3. Andrological aspects of prolactin secretion disorders;Andrology and Genital Surgery;2023-09-12